Andrew Avarbock

591 total citations
9 papers, 442 citations indexed

About

Andrew Avarbock is a scholar working on Dermatology, Epidemiology and Infectious Diseases. According to data from OpenAlex, Andrew Avarbock has authored 9 papers receiving a total of 442 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Dermatology, 4 papers in Epidemiology and 3 papers in Infectious Diseases. Recurrent topics in Andrew Avarbock's work include Tuberculosis Research and Epidemiology (3 papers), Cancer therapeutics and mechanisms (2 papers) and Cancer and Skin Lesions (2 papers). Andrew Avarbock is often cited by papers focused on Tuberculosis Research and Epidemiology (3 papers), Cancer therapeutics and mechanisms (2 papers) and Cancer and Skin Lesions (2 papers). Andrew Avarbock collaborates with scholars based in United States. Andrew Avarbock's co-authors include David Avarbock, Harvey Rubin, Takahiro Yano, Andrew A. McColm, Edward A. Weinstein, Douglas L. Helm, Linsheng Li, Ken Duncan, John T. Lonsdale and Zhimei Wang and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Biochemistry and American Journal of Hematology.

In The Last Decade

Andrew Avarbock

8 papers receiving 435 citations

Peers

Andrew Avarbock
Hoonsik Cho United States
Andrew Avarbock
Citations per year, relative to Andrew Avarbock Andrew Avarbock (= 1×) peers Hoonsik Cho

Countries citing papers authored by Andrew Avarbock

Since Specialization
Citations

This map shows the geographic impact of Andrew Avarbock's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Andrew Avarbock with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Andrew Avarbock more than expected).

Fields of papers citing papers by Andrew Avarbock

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Andrew Avarbock. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Andrew Avarbock. The network helps show where Andrew Avarbock may publish in the future.

Co-authorship network of co-authors of Andrew Avarbock

This figure shows the co-authorship network connecting the top 25 collaborators of Andrew Avarbock. A scholar is included among the top collaborators of Andrew Avarbock based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Andrew Avarbock. Andrew Avarbock is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

9 of 9 papers shown
1.
Avarbock, Andrew, et al.. (2020). Rapid resolution of pyoderma gangrenosum with brodalumab therapy. JAAD Case Reports. 6(11). 1167–1169. 18 indexed citations
2.
Avarbock, Andrew, et al.. (2018). Orofacial granulomatosis and erythema multiforme in an adolescent with Crohn's disease. Pediatric Dermatology. 35(5). e294–e297. 2 indexed citations
3.
Coates, Sarah J., Andrew Avarbock, & Garrett Desman. (2017). Giant benign intradermal melanocytic nevus of rapid onset. Dermatology Online Journal. 23(2).
4.
Scher, Richard K., et al.. (2015). Acquired Congenital Malalignment of the Great Toenails. Skin Appendage Disorders. 1(3). 147–149. 12 indexed citations
5.
Suárez, Andrea, Hillary Johnson, Garrett Desman, & Andrew Avarbock. (2015). Post-radiation atypical vascular proliferation on the head of a young woman: a diagnostic challenge. Dermatology Online Journal. 21(6). 1 indexed citations
6.
Avarbock, Andrew, Alison W. Loren, Jason Y. Park, et al.. (2008). Lethal vascular leak syndrome after denileukin diftitox administration to a patient with cutaneous gamma/delta T‐cell lymphoma and occult cirrhosis. American Journal of Hematology. 83(7). 593–595. 22 indexed citations
7.
Weinstein, Edward A., Takahiro Yano, Linsheng Li, et al.. (2005). Inhibitors of type II NADH:menaquinone oxidoreductase represent a class of antitubercular drugs. Proceedings of the National Academy of Sciences. 102(12). 4548–4553. 219 indexed citations
8.
Avarbock, Andrew, David Avarbock, J. S. Teh, et al.. (2005). Functional Regulation of the Opposing (p)ppGpp Synthetase/Hydrolase Activities of RelMtb from Mycobacterium tuberculosis. Biochemistry. 44(29). 9913–9923. 80 indexed citations
9.
Avarbock, David, Andrew Avarbock, & Harvey Rubin. (2000). Differential Regulation of Opposing RelMtb Activities by the Aminoacylation State of a tRNA·Ribosome·mRNA·RelMtb Complex. Biochemistry. 39(38). 11640–11648. 88 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026